Revenue FY2025
$31.0M
Net Income
$(209.0M)
EPS (Basic)
$-3.02
Net Margin
-677.6%
ROE
-366.2%
Total Equity
$57.0M
Shares Out
91M
Verastem, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Torray Funds
Torray
$1.8M
0.2%
+59.7%
Baker Bros. Advisors
Baker Bros. Advisors
$9.5M
0.0%
+327.4%
Insider Transactions
Reading stored insider transactions…